Cargando…
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia
Activating G protein-coupled estrogen receptor 1 (GPER1) is an attractive therapeutic strategy for treating a variety of human diseases including cancer. Here, we show that GPER1 is significantly upregulated in tumor cells from different cohorts of Waldenström Macroglobulinemia (WM) patients compare...
Autores principales: | Morelli, Eugenio, Hunter, Zachary R., Fulciniti, Mariateresa, Gullà, Annamaria, Perrotta, Ida Daniela, Zuccalà, Valeria, Federico, Cinzia, Juli, Giada, Manzoni, Martina, Ronchetti, Domenica, Romeo, Enrica, Gallo Cantafio, Maria Eugenia, Soncini, Debora, Maltese, Lorenza, Rossi, Marco, Roccaro, Aldo M., Cea, Michele, Tassone, Pierfrancesco, Neri, Antonino, Treon, Steven C., Munshi, Nikhil C., Viglietto, Giuseppe, Amodio, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469525/ https://www.ncbi.nlm.nih.gov/pubmed/36096954 http://dx.doi.org/10.1186/s40164-022-00305-x |
Ejemplares similares
-
Genomic landscape of Waldenström's macroglobulinemia
por: Treon, Steven P., et al.
Publicado: (2019) -
The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions
por: Sacco, Antonio, et al.
Publicado: (2017) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022) -
Venetoclax in Previously Treated Waldenström Macroglobulinemia
por: Castillo, Jorge J., et al.
Publicado: (2022) -
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia
por: Castillo, Jorge J., et al.
Publicado: (2023)